Polianta Ltd’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-34,500
Closed -$1.23M 114
2023
Q1
$1.23M Buy
34,500
+11,800
+52% +$428K 0.56% 24
2022
Q4
$832K Buy
+22,700
New +$897K 0.62% 22

Other funds holding SYNH

Polianta Ltd's SYNH Position: Q2 2023 in Review

Polianta Ltd sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 34,500 shares — an estimated $1.23M sold.

Polianta Ltd first reported a position in SYNH in Q4 2022 and held it in 2 quarters. The position peaked at $1.23M in Q1 2023. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Polianta Ltd reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Polianta Ltd sold 34,500 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $1.23M.
  • Polianta Ltd first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2022 and held it in 2 quarters.
  • Polianta Ltd's Syneos Health, Inc. Class A Common Stock position peaked at $1.23M in Q1 2023.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Polianta Ltd's 13F filing for Q2 2023, filed 19 Jul 2023.